| Informed consent and the use of transvaginal synthetic mesh. | |
| | |
MedLine Citation:
|
PMID: 22105272 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
In 2008 and again in July of this year, the U.S. Food and Drug Administration (FDA) issued safety communications regarding the use of transvaginally placed surgical mesh. These FDA communications have been the subject of much discussion in the literature. One issue raised by these communications and in the medical literature is the matter of informed consent. Informed consent is an established bioethical principle in modern health care, but it is evolving. The legal interpretations of informed consent are also in flux. A review of contemporary ethical and legal elements of informed consent is presented as it relates to the use of medical innovation, with a focus on transvaginally placed surgical mesh. |
| | |
Authors:
|
James L Whiteside |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 118 ISSN: 1873-233X ISO Abbreviation: Obstet Gynecol Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-11-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 1409-16 Citation Subset: AIM; IM |
Affiliation:
|
From the Department of Obstetrics and Gynecology, Dartmouth Medical School, Lebanon, New Hampshire. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nomenclature for pregnancy outcomes: time for a change.
Next Document: A luminescent bacterium assay of fusaric acid produced by Fusarium proliferatum from banana.